Mark Levine Insider Profile

4 Followers
Mark Levine, SVP,GC & Sec at Minerva Neurosciences, holds 322.88K shares in Immunovant (Ticker: IMVT), holds 0.00 shares in Flexion Therapeutics (Ticker: FLXN), holds 0.00 shares in Minerva Neurosciences (Ticker: NERV). Most recently, Mark Levine Sold ― shares of Immunovant on Oct 25, 2024 for an estimated value of 128.78K.
tipranks
Mark Levine

Mark Levine
Minerva Neurosciences (NERV)
SVP,GC & Sec

Ranked #83,231 out of 99,218 Corporate Insiders

Profitable Transactions

44%
7 out of 16 Profitable Transactions

Average Return

-13.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
100.00%
0.00%
A breakdown of Mark Levine's holdings

Insider Roles

Immunovant
(IMVT)
CLO
Minerva Neurosciences
(NERV)
SVP,GC & Sec
Roles that Mark Levine holds in companies

Most Profitable Insider Trade

Stock:
Immunovant
(IMVT)
Rating:Informative Sell
Date:Jan 29, 2024 - Today
Return:+25.20%
The most profitable trade made by Mark Levine

Mark Levine's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Minerva Neurosciences
Jun 05, 2017
SVP,GC & Sec
Uninformative Buy
90.83K
$0.00
FLXN
Flexion Therapeutics
Nov 19, 2021
Uninformative Sell
1.13M
$0.00
Immunovant
Oct 25, 2024
CLO
Informative Sell
128.78K
$9.90M
List of latest transactions for each holding click on a transaction to see Mark Levine's performance on stock

Mark Levine insider profile FAQ

What is the percentage of profitable transactions made by Mark Levine?
The percentage of profitable transactions made by Mark Levine is 44%.
    What is the average return per transaction made by Mark Levine?
    The average return per transaction made by Mark Levine is -13.70%.
      What stocks does Mark Levine hold?
      Mark Levine holds: NERV, FLXN, IMVT stocks.
        What was Mark Levine’s latest transaction?
        Mark Levine latest transaction was an Informative Sell of $128.78K.
          What was Mark Levine's most profitable transaction?
          Mark Levine’s most profitable transaction was an Informative Sell of IMVT stock on January 29, 2024. The return on the trade was 25.20%.
            What is Mark Levine's role in Minerva Neurosciences?
            Mark Levine's role in Minerva Neurosciences is SVP,GC & Sec.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.